Objectives: Despite the US Preventive Services Task Force recommendation against screening mammography in women younger than 50 years, rates remain high, suggesting that screening recommendations may be motivated by other factors. The objective of this study was to understand provider-reported influences on screening recommendations for women 40 to 49 years old at average risk for breast cancer.
B
reast cancer is the second leading cause of cancer death among women in the United States. 1 Expert physical breast examination may be specific but insensitive. Mammography is the most effective screening tool for reducing breast cancer mortality 2 ; however, the benefits vary by age. 3 For women younger than 50 years, both the sensitivity and specificity of mammography are low as a result of more extensive dense breast tissue in premenopausal women. This leads to a high rate of false-positive findings in women younger than 50, 4, 5 as well as the possibility of being treated for a cancer that otherwise would never have become symptomatic. 6 In 1997, the National Cancer Institute Consensus Development Conference on Mammographic Screening did not recommend routine screening for women 40 to 49 years old considered to be at normal risk for breast cancer. 7 The 2009 US Preventive Services Task Force (USPSTF) statement also did not support routine screening for this group, stating that the decision to start regular, biennial screening mammography before age 50 years should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms. 8 This recommendation was a given a C grade by the USPSTF, meaning they believed that there was high to moderate certainty that the magnitude of the net benefit was small and may not justify the risk. 9 In 2016 the USPSTF reaffirmed this position in their updated recommendation statement. 10 Since the 2009 change in the USPSTF recommendation against routine screening in this age group, screening rates have remained largely static, however. [11] [12] [13] [14] In addition to guidelines, providers face numerous factors that may influence their recommendation for breast cancer screening in younger women. Annual mammography for women older than 40 is a common institutional quality measure, 15 which often is linked to provider compensation. 16 Electronic health records with provider-facing reminder systems also have been shown to influence provider cancer-screening behavior, 15, 17 as have providers' personal valuations of the balance of risks and benefits of screening. 18 More important, as underscored by the USPSTF in its 2016 recommendation statement, a key influence on provider recommendations should be the patient's screening preference based on an informed understanding of risks and benefits. 8, 10 There has been some work examining provider attitudes and beliefs regarding screening and screening recommendations for women 40 to 49 years old at average risk for breast cancer. [18] [19] [20] [21] [22] These studies found provider variability in the endorsement of USPSTF guidelines, as well as differences in provider beliefs about the effectiveness of screening mammography in younger women. 18, 20, 21 This prior research, however, did not focus explicitly on mammography for women younger than 50 years at average risk for cancer. Furthermore, no research specifically inquired about providers' perspectives on different sources of influence on their mammography screening recommendations in younger women. As a result, our understanding of what motivates provider screening recommendations in this age group remains limited. This study had two objectives. The first was to characterize provider factors associated with routine recommendation of mammography for women aged 40 to 49 at average risk for breast cancer, and the second was to explore the association of various sources of influence on provider recommendation for mammography screening in younger women at average risk.
Methods

Survey and Study Population
The data for this study come from a survey of primary care providers in the greater Cleveland, Ohio area, conducted between January and April 2015. Participants were recruited from four major health systems: Cleveland Clinic, MetroHealth, Care Alliance, and Neighborhood Family Practice. Potentially eligible primary care providers (N = 612) were identified via communication with each health system, who provided e-mail addresses for all of the primary care providers within their respective system. Eligible survey respondents were primary care physicians or nonphysician providers with mammographyordering privileges (eg, nurse practitioners).
Following an e-mail invitation to participate, providers were directed via an Internet link to an online anonymous survey administered through REDCap (Vanderbilt University, Nashville, TN). 23 Potential participants were informed that upon completion of the survey, they would have the opportunity for their name to be entered into a raffle to win either one $100 gift card or one of six $25 gift cards. Provider consent was assumed by survey completion. This study was approved by the institutional review board of the Cleveland Clinic, which served as the institutional review board of record for the other participating institutions.
Screening Recommendations
Our primary outcome measure was whether providers reported routinely recommending mammography. This was assessed via provider self-report to the item "Do you routinely recommend screening mammography for women aged 40-49 years with average risk?" with response categories of "yes" or "no."
Provider Characteristics
The survey collected data on provider characteristics, including sex and whether providers practiced in an academic setting or a community-based setting. To account for providers who trained and/or practiced before the 2009 USPSTF recommendation change, we included an additional variable of years of experience, which we categorized as "5 years or more posttraining experience," "less than 5 years posttraining experience," or "resident" (ie, trainee).
Factors Influencing Screening
The survey asked providers to state the extent to which seven factors influenced their mammography screening recommendations for women aged 40 to 49 at average risk for breast cancer, which were based on a comprehensive review of the literature. These seven factors were the influence of national guidelines, institutional policy, electronic medical records (EMR) reminder systems, patient preferences, concerns about overtreatment, concerns about false-positive findings, and interest in early detection of breast cancer. Four level-response categories ranged from "not at all" to "a lot." Because we were interested in which factors were most influential in providers' screening recommendations, we dichotomized each of these items as heavily influencing screening recommendations (survey response of "a lot") compared with not heavily influencing recommendations (survey response of anything less than "a lot").
Provider Perception of the Balance of Harms and Benefits
To account for the influence of provider beliefs regarding the balance of harms and benefits of mammography, we included a vignette-type item: "Consider the following scenario: A 40-year-old otherwise healthy female patient with no family history of breast cancer would like to know about the benefits and harms of a screening mammogram. Considering this patient, which do you think is true?" Response options included "benefits of screening outweigh risks," "harms of screening outweigh benefits," and "benefits and harms of screening are similar and/ or equal."
Statistical Analysis
We first generated distributions and descriptive statistics for all of the key variables. We then examined bivariate associations between provider characteristics and screening influences with self-reported routine recommendation of mammography using the χ 2 statistic (or Fisher's exact test, when appropriate). We used multivariable logistic regression to estimate the odds of recommending routine screening by provider-reported screening influences, controlling for provider characteristics and providerassessed balance of harms and benefits of screening in this age group. The multivariable regression model included only providers for whom we had complete survey data on model variables (n = 188). All of the analyses were completed in STATA 14 (StataCorp, College Station, TX).
Results
Of the 612 primary care providers contacted via e-mail, 220 completed the survey, for an overall response rate of 36%. Among these respondents, 50% were women and 62% practiced in an academic setting. More than half of the sample (56%) reported having ≥5 years' posttraining experience, and 17% were residents. Overall, 69% of providers reported routinely recommending mammography for women aged 40 to 49 at average risk for breast cancer. Table 1 presents sample characteristics and bivariate comparisons between sample characteristics and routine recommendation of mammography.
More than 60% of providers reported being heavily influenced by national guidelines and half reported being heavily influenced by institutional policy. Comparatively fewer (<20%) reported being heavily influenced by concerns about overtreatment or concerns about false-positives. In their assessment of the balance of harms and benefits of screening, 43% of providers believed that the benefits outweighed the harms, 24% believed that the harms outweighed the benefits, and 33% believed that the harms and benefits were equal. In the bivariate analyses, female providers were significantly more likely than male providers to recommend routine screening, as were providers practicing in a community-based setting, and those with ≥5 years of posttraining experience. Reporting being heavily influenced by EMR reminders, institutional policy, and an interest in early detection also was associated with recommending routine screening, whereas concerns regarding overtreatment and false-positive findings were associated with not recommending screening. Patient preferences and national guidelines were not associated with recommendation of routine screening in the bivariate analyses. Provider assessment of the balance of benefits and harms of screening in younger women also was significantly associated with screening recommendation. Of the 24% of providers who reported that they believed that the harms of screening in women 40 to 49 years old outweighed the benefits, 33% routinely recommended screening. Compared with those who believed that the balance of harms and benefits associated with screening was equal, providers who believed the harms of screening outweighed the benefits were significantly less likely to recommend screening (OR 0.07, 95% CI 0.02-0.31). Those who believed the benefits of screening outweighed the harms were no more likely to routinely recommend screening, however.
Having a strong interest in the early detection of cancer (OR 5.09, 95% CI 1.69-15.3) or being influenced by institutional policy (OR 4.19, 95% CI 1.35-12.9) was associated with a greater likelihood of routinely recommending screening, whereas being heavily influenced by national guidelines was associated with a lower likelihood of recommending screening (OR 0.25, 95% CI 0.09-0.71). There were no significant associations between the influence of patient preferences, concern about overtreatment, concern about false-positives, or EMR reminders and odds of recommending routine screening in the adjusted model.
Discussion
In 2009, the USPSTF changed its recommendation on screening mammography for women younger than age 50, finding that the harms generally outweighed the benefits. Since then, numerous studies have documented persistently high rates of screening mammography in this age group. [11] [12] [13] [14] In our survey of primary care providers, the majority reported routinely recommending screening for women under 50. Although most believed that the benefits of screening were at least equal to the harms, onethird of those who believed that the harms outweighed the benefits nonetheless routinely recommended screening. Providers who reported being heavily influenced by institutional policy or reported a strong interest in early detection were more likely to recommend screening, whereas those who stated they were heavily influenced by national guidelines were less likely to recommend it. Female providers and those practicing in community-based practices also were more likely to recommend screening, and residents were less likely to recommend screening.
Providers who reported being heavily influenced by institutional policy in screening decisions were more likely to recommend screening. Institutional policies regarding cancer screening, promoted via provider incentives and reminder systems, are associated with increased recommendation and completion of screening in eligible patient populations. 17 Until 2009, as was reflected in the prior USPSTF guideline, the consensus was that most women should initiate mammography at age 40, and this consensus informed institutional policy. Despite the USPSTF's new recommendation, and partly as a result of both patient and provider reactions, provisions of the Patient Protection and Affordable Care Act (PL 111-148) mandated in 2010 that mammography be covered beginning at age 40. 24 Consequently, healthcare systems have financial incentives to maintain existing policies that promote mammography. Most women expect their primary care provider to only recommend care with a favorable balance of benefits compared with harms. We found that providers' assessments of the balance of benefits and harms of mammography in this age group varied substantially, yet institutional policy affected mammography screening recommendations nonetheless. Similarly, results of a primary care provider survey found that despite perceiving mammography to be ineffective in younger women, most physicians reported ordering mammography anyway. 19 These findings raise concerns regarding providers' institutional incentives to practice informed and patient-centered decision making for mammography with younger patients.
Consensus is growing that cancer screening decisions should be based on patient preferences and values, as well as the individual predicted risks and benefits of screening. 25 For women younger than age 50 at average risk of breast cancer, the USPSTF recommends providers engage in shared decision making with patients to individualize screening decisions. 8 Similarly, the American Cancer Society recommends that women be counseled on benefits, harms, and limitations of mammography before screening. 26 Central to this process is the elucidation and consideration of patient values and preferences around the specific benefits and harms associated with screening. Physicians who value patient preference should therefore not routinely order mammograms, but rather do so on a case-by-case basis. Although nearly 60% of providers in our study reported being heavily influenced by patient preferences for screening, these providers were no less likely to routinely recommend mammography in our adjusted model. This is consistent with results from a survey of US women in which less than one-third of those younger than age 50 perceived that they had a choice regarding mammography. 27 Prior research shows that providers who endorse the revised USPSTF guidelines are less likely than providers who did not endorse the guidelines to screen younger women. 19, 20 Indeed, being heavily influenced by national guidelines was associated with a lower odds of routinely recommending screening in our adjusted model. That said, a majority of providers in our study reported being influenced heavily by national guidelines; however, two-thirds nonetheless reported routinely recommending screening to younger women at average risk, a phenomenon that has been previously documented. 22 It is important to note that the USPSTF guideline is not universally endorsed by providers, and other guidelines conflict. 18, 20, 21, [28] [29] [30] The American Cancer Society has revised its recommendation of screening initiation at age 40 to instead endorse screening initiation at age 45, 26 further complicating the landscape of screening recommendations for younger women. For those providers who attempt to assess the totality of evidence underlying multiple guidelines, the existence of conflicting recommendations may complicate their screening recommendations. 31 Similarly, patient anxiety and confusion regarding multiple conflicting guidelines 32, 33 underscore the need for clear patient-centered provider communication about the harms and benefits of screening.
Evidence supporting the impact of early detection of breast cancer on mortality is controversial, 4, 34 and there is considerable evidence that widespread screening leads to overtreatment. 6, 35, 36 In particular, diagnosis of ductal carcinoma in situ is common in younger women, 37 ,38 yet the utility of treatment for ductal carcinoma in situ is questionable. 39, 40 In our survey, 42% of providers reported a strong interest in the early detection of breast cancer, and these providers were significantly more likely to recommend screening. In contrast, only 19% of providers reported being heavily influenced by concerns about overtreatment, and this influence was not significant in the adjusted model. This suggests that providers' beliefs regarding the benefits of early detection outweigh concerns about overtreatment in driving screening recommendations for younger women. It is unknown, however, to what extent providers' understanding of the benefit of early detection and risk of overtreatment is informed by medical evidence. In light of this, proposals to cease designation of noninvasive (in situ) lesions as "cancer" should be considered. 41 To our knowledge, our study is the first to document differences in mammography recommendation by practice setting. Community-based providers as compared with those in academic settings were significantly more likely to routinely recommend screening. We did not find differences in the influence of institutional policy on screening recommendations between academic and community-based providers (data not presented). This suggests that differences in screening recommendations by practice setting in our study are likely not the result of dissimilar incentive structures. Some prior research showed higher rates of physician recommendation of prostate cancer screening among community-based compared with academic providers. 42, 43 Community-based practices often lag behind those in academic settings in implementing novel technology. 42 It is possible that the same could be true for "de-innovation" of certain healthcare services, 44 or the scaling back of commonly used interventions, newly understood to have questionable value.
Our study has some limitations. Routine recommendation of mammography was based on provider self-report; actual screening recommendations could not be confirmed. In addition, we developed novel measures of perceived screening influences that have not been validated previously. Because our survey was cross-sectional, we have no information regarding providers' screening recommendations before 2009. Consequently, we do not know whether the influence of national guidelines on provider screening recommendations shifted over time. Moreover, the survey did not distinguish between the USPSTF guidelines and other professional society guidelines in our item assessing the extent to which national guidelines influenced provider screening recommendations. Given that being heavily influenced by national guidelines was associated with a lower likelihood of routinely recommending screening, it is likely that most providers interpreted this question as referring to the USPSTF guidelines. In addition, because our study sample was restricted to providers in the greater Cleveland area, respondents may not be representative of providers from other geographic areas. Finally, this study had a fairly low overall response rate (36%); however, this is a common limitation in Web-based surveys of physicians. 45 Moreover, this limitation should apply more to the representativeness of overall rates (eg, how many routinely screen) than to the associations between physician influences and their reported practices.
Conclusions
In our study of primary care providers, most routinely recommended screening for women aged 40 to 49 at average risk for breast cancer, including many providers who believed that the harms of screening outweighed the benefits. Although the influence of patient preferences was not significantly associated with screening recommendation, institutional policy was associated. Patient preferences, however, are particularly important when medical data are ambiguous. Our findings suggest implementation of shared decision making for mammography in this age group likely faces institutional challenges. Changes to institutional mammography quality measures to incentivize and provide time for screening discussions over screening outcomes may improve patient-centered care in this controversial domain.
